芪苈强心胶囊为主治疗难治性心力衰竭的临床观察

Therapeutic effect of Qiliqiangxin capsule combined on refractory heart failure

目的 观察芪苈强心胶囊为主治疗难治性心力衰竭的临床疗效.方法 将60例顽固性心力衰竭患者随即分为两组各30例,对照组为常规药物治疗,治疗组在常规治疗的基础上加用芪苈强心胶囊（4粒/次,3次/d）,疗程均14 d.结果 治疗14 d后,治疗组心衰症状明显改善,与对照组比较差异有统计学意义（χ2=6.267,P＜0.05）.结论 芪苈强心胶囊为主治疗难治性心力衰竭疗效满意.

Objective To observe the therapeutic effect of Qiliqiangxin capsule combined on refractory heart failure.Methods 60 patients with refractory heart failure were randomly recruited into a control group and a therapeutic group. The control group received the conventional treatment, and the therapeutic group took Qiliqiangxin capsule on the base of the conventional treatment （3 times a day, 4 granules/each time） combined with 120 mg cAMP meglumine. Treatment in both group lasted 14 days. Results： After the treatment, the therapeutic group showed improvement in the symptoms of heart failure. Comparing with the control group, the difference was significant （P＜0.05）. Conclusion The therapeutic effect of Qiliqiangxin capsule combined on refractory heart failure is satisfied and can improve the quality obviously.